Skip to main content
Top
Published in: Cancer Causes & Control 9/2009

01-11-2009 | Original paper

Trends in adult leukemia incidence and survival in Denmark, 1943–2003

Authors: Lau Caspar Thygesen, Ove Juul Nielsen, Christoffer Johansen

Published in: Cancer Causes & Control | Issue 9/2009

Login to get access

Abstract

The etiology of leukemia is largely unknown. Ecological data indicating trends in incidence and survival can provide information about changes in risk factors, can reflect underlying changes in diagnostic classification, and can measure therapeutic advances. From the records of the Danish Cancer Registry with registration starting from 1943, we calculated age-specific, period-specific, and age-standardized (world standard) incidence rates of chronic lymphoid leukemia (CLL), acute lymphoid leukemia (ALL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML) for persons above the age of 18. Kaplan–Meier survival curves and median survival times were calculated. Between 1943 and 2003, there were 26,036 cases of leukemia reported. The age-specific incidence rates of CLL, CML, and AML were higher for older men and women, while the incidence rates of ALL by age were more homogeneous. The age-standardized incidence rates during the study period increased for CLL and AML, increased less strongly for ALL, and decreased for CML in both men and women, although the incidence rates for women were almost always lower. Patients with CLL had the longest survival time in all age groups. The median survival time increased for all leukemia subtypes throughout the period of study most pronounced for CLL since 1950 and CML since 1990.
Literature
1.
go back to reference Petridou E, Trichopoulos D (2002) Leukemias. In: Adami H-O, Hunter D, Trichopoulos D (eds) Textbook in cancer epidemiology. Oxford University Press, Oxford, pp 556–572 Petridou E, Trichopoulos D (2002) Leukemias. In: Adami H-O, Hunter D, Trichopoulos D (eds) Textbook in cancer epidemiology. Oxford University Press, Oxford, pp 556–572
2.
go back to reference The National Board of Health HS (2003) Cancer incidence in Danmark 1999. National Board of Health, København The National Board of Health HS (2003) Cancer incidence in Danmark 1999. National Board of Health, København
3.
go back to reference Blair V, Birch JM (1994) Patterns and temporal trends in the incidence of malignant disease in children: I. Leukaemia and lymphoma. Eur J Cancer 30A:1490–1498CrossRefPubMed Blair V, Birch JM (1994) Patterns and temporal trends in the incidence of malignant disease in children: I. Leukaemia and lymphoma. Eur J Cancer 30A:1490–1498CrossRefPubMed
4.
go back to reference Kwiatkowski A (1994) Trends in the incidence of leukaemia in Poland, 1963–90: an epidemiologic study. Eur J Cancer Prev 3:277–283CrossRefPubMed Kwiatkowski A (1994) Trends in the incidence of leukaemia in Poland, 1963–90: an epidemiologic study. Eur J Cancer Prev 3:277–283CrossRefPubMed
5.
go back to reference Groves FD, Linet MS, Devesa SS (1995) Patterns of occurrence of the leukaemias. Eur J Cancer 31A:941–949CrossRefPubMed Groves FD, Linet MS, Devesa SS (1995) Patterns of occurrence of the leukaemias. Eur J Cancer 31A:941–949CrossRefPubMed
6.
go back to reference Kaatsch P, Haaf G, Michaelis J (1995) Childhood malignancies in Germany—methods and results of a nationwide registry. Eur J Cancer 31A:993–999CrossRefPubMed Kaatsch P, Haaf G, Michaelis J (1995) Childhood malignancies in Germany—methods and results of a nationwide registry. Eur J Cancer 31A:993–999CrossRefPubMed
7.
go back to reference Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL (1996) Trends in cancer incidence among children in the US. Cancer 78:532–541CrossRefPubMed Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL (1996) Trends in cancer incidence among children in the US. Cancer 78:532–541CrossRefPubMed
8.
go back to reference McNally RJ, Rowland D, Roman E, Cartwright RA (1997) Age and sex distributions of hematological malignancies in the UK. Hematol Oncol 15:173–189CrossRefPubMed McNally RJ, Rowland D, Roman E, Cartwright RA (1997) Age and sex distributions of hematological malignancies in the UK. Hematol Oncol 15:173–189CrossRefPubMed
9.
go back to reference Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK (1998) Cancer incidence and mortality, 1973–1995: a report card for the US. Cancer 82:1197–1207CrossRefPubMed Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK (1998) Cancer incidence and mortality, 1973–1995: a report card for the US. Cancer 82:1197–1207CrossRefPubMed
10.
go back to reference Linet MS, Ries LA, Smith MA, Tarone RE, Devesa SS (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051–1058CrossRefPubMed Linet MS, Ries LA, Smith MA, Tarone RE, Devesa SS (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051–1058CrossRefPubMed
11.
go back to reference McNally RJ, Roman E, Cartwright RA (1999) Leukemias and lymphomas: time trends in the UK, 1984–93. Cancer Causes Control 10:35–42CrossRefPubMed McNally RJ, Roman E, Cartwright RA (1999) Leukemias and lymphomas: time trends in the UK, 1984–93. Cancer Causes Control 10:35–42CrossRefPubMed
12.
go back to reference McNally RJ, Birch JM, Taylor GM, Eden OB (2000) Incidence of childhood precursor B-cell acute lymphoblastic leukaemia in north-west England. Lancet 356:485–486CrossRefPubMed McNally RJ, Birch JM, Taylor GM, Eden OB (2000) Incidence of childhood precursor B-cell acute lymphoblastic leukaemia in north-west England. Lancet 356:485–486CrossRefPubMed
13.
go back to reference McNally RJ, Cairns DP, Eden OB, Kelsey AM, Taylor GM, Birch JM (2001) Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues. Leukemia 15:1612–1618CrossRefPubMed McNally RJ, Cairns DP, Eden OB, Kelsey AM, Taylor GM, Birch JM (2001) Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues. Leukemia 15:1612–1618CrossRefPubMed
14.
go back to reference Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA (2003) Trends in leukemia incidence and survival in the United States (1973–1998). Cancer 97:2229–2235CrossRefPubMed Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA (2003) Trends in leukemia incidence and survival in the United States (1973–1998). Cancer 97:2229–2235CrossRefPubMed
15.
go back to reference Yamamoto JF, Goodman MT (2008) Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control 19:379–390CrossRefPubMed Yamamoto JF, Goodman MT (2008) Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control 19:379–390CrossRefPubMed
16.
go back to reference Roswall N, Olsen A, Christensen J, Rugbjerg K, Mellemkjaer L (2008) Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994–2003. Eur J Cancer 44:2058–2073CrossRefPubMed Roswall N, Olsen A, Christensen J, Rugbjerg K, Mellemkjaer L (2008) Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994–2003. Eur J Cancer 44:2058–2073CrossRefPubMed
17.
go back to reference Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–57). Tohoku University School of Public Health, Sendai Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–57). Tohoku University School of Public Health, Sendai
18.
go back to reference Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M (2000) Age standardization of rates: a new WHO standard. World Health Organization. GPE Discussion Paper Series: No. 31 Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M (2000) Age standardization of rates: a new WHO standard. World Health Organization. GPE Discussion Paper Series: No. 31
19.
go back to reference Clemmensen IH, Nedergaard KH, Storm HH (2006) Cancer in Denmark [in Danish]. FADL’s forlag, Copenhagen Clemmensen IH, Nedergaard KH, Storm HH (2006) Cancer in Denmark [in Danish]. FADL’s forlag, Copenhagen
20.
go back to reference Izraeli S, Rainis L, Hertzberg L, Smooha G, Birger Y (2007) Trisomy of chromosome 21 in leukemogenesis. Blood Cells Mol Dis 39:156–159CrossRefPubMed Izraeli S, Rainis L, Hertzberg L, Smooha G, Birger Y (2007) Trisomy of chromosome 21 in leukemogenesis. Blood Cells Mol Dis 39:156–159CrossRefPubMed
21.
go back to reference Johansen C (2004) Electromagnetic fields and health effects—epidemiologic studies of cancer, diseases of the central nervous system and arrhythmia-related heart disease. Scand J Work Environ Health 30(Suppl 1):1–30PubMed Johansen C (2004) Electromagnetic fields and health effects—epidemiologic studies of cancer, diseases of the central nervous system and arrhythmia-related heart disease. Scand J Work Environ Health 30(Suppl 1):1–30PubMed
22.
go back to reference Jaffe ES, Harris NL, Stein H et al (2001) World Health Organization classification of tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon Jaffe ES, Harris NL, Stein H et al (2001) World Health Organization classification of tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon
23.
go back to reference Dogan A (2005) Modern histological classification of low grade B-cell lymphomas. Best Pract Res Clin Haematol 18:11–26CrossRefPubMed Dogan A (2005) Modern histological classification of low grade B-cell lymphomas. Best Pract Res Clin Haematol 18:11–26CrossRefPubMed
24.
go back to reference Head DR (2002) Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful? Curr Opin Oncol 14:19–23CrossRefPubMed Head DR (2002) Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful? Curr Opin Oncol 14:19–23CrossRefPubMed
25.
go back to reference Aurran-Schleinitz T, Arnoulet C, Ivanov V et al (2008) Chronic lymphocytic leukaemia: current management. Rev Med Interne 29:424–435CrossRefPubMed Aurran-Schleinitz T, Arnoulet C, Ivanov V et al (2008) Chronic lymphocytic leukaemia: current management. Rev Med Interne 29:424–435CrossRefPubMed
26.
go back to reference Moreno C, Montserrat E (2008) New prognostic markers in chronic lymphocytic leukemia. Blood Rev 22:211–219CrossRefPubMed Moreno C, Montserrat E (2008) New prognostic markers in chronic lymphocytic leukemia. Blood Rev 22:211–219CrossRefPubMed
27.
go back to reference Larson S, Stock W (2008) Progress in the treatment of adults with acute lymphoblastic leukemia. Curr Opin Hematol 15:400–407CrossRefPubMed Larson S, Stock W (2008) Progress in the treatment of adults with acute lymphoblastic leukemia. Curr Opin Hematol 15:400–407CrossRefPubMed
28.
go back to reference Fausel C (2007) Targeted chronic myeloid leukemia therapy: seeking a cure. J Manag Care Pharm 13:8–12PubMed Fausel C (2007) Targeted chronic myeloid leukemia therapy: seeking a cure. J Manag Care Pharm 13:8–12PubMed
29.
go back to reference Pinilla-Ibarz J, Bello C (2008) Modern approaches to treating chronic myelogenous leukemia. Curr Oncol Rep 10:365–371CrossRefPubMed Pinilla-Ibarz J, Bello C (2008) Modern approaches to treating chronic myelogenous leukemia. Curr Oncol Rep 10:365–371CrossRefPubMed
30.
go back to reference Ravandi F, Burnett AK, Agura ED, Kantarjian HM (2007) Progress in the treatment of acute myeloid leukemia. Cancer 110:1900–1910CrossRefPubMed Ravandi F, Burnett AK, Agura ED, Kantarjian HM (2007) Progress in the treatment of acute myeloid leukemia. Cancer 110:1900–1910CrossRefPubMed
31.
go back to reference Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish cancer registry—history, content, quality and use. Dan Med Bull 44:535–539PubMed Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish cancer registry—history, content, quality and use. Dan Med Bull 44:535–539PubMed
Metadata
Title
Trends in adult leukemia incidence and survival in Denmark, 1943–2003
Authors
Lau Caspar Thygesen
Ove Juul Nielsen
Christoffer Johansen
Publication date
01-11-2009
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 9/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9417-9

Other articles of this Issue 9/2009

Cancer Causes & Control 9/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine